Indmedica Home | About Indmedica | Medical Jobs | Advertise On Indmedica
Search Indmedica Web
Indmedica - India's premier medical portal

Biomedical Research

Occurrence of rheumatoid factor, anticardiolipin antibody and antinuclear antibody in healthy Indian adults (greater than expected in young adults)

Author(s): Lingaraj Jayalakshmi, Chandrashekara S., H.B.Veeranna

Vol. 22, No. 3 (2011-07 - 2011-09)

Lingaraj Jayalakshmi1, Chandrashekara S.2, H.B.Veeranna3

(1) Department of physiology, Vydehi Institute of Medical Sciences and Research Center, Bangalore, India
(2) Chanre Rheumatology & Immunology Centre and Research, Bangalore, India (formerly Department of immu-nology, Ramaiah medical college and hospital, Bangalore)
(3) Department of physiology, Chennai Medical College Hospital and Research Centre, Trichy, India

Abstract

Autoantibodies like Rheumatoid factor (RF), Anticardiolipin antibody (ACLA) normally used in diagnosing autoimmune diseases have also been identified in healthy individuals. The presence of such autoantibodies could alter their diagnostic and predictive value. Oc-currence of these autoantibodies have been shown to vary with age, geographical location and other environmental factors. This study was done as an attempt to find the occurrence of RF,ACLA and ANA in healthy adults in South Indian population and to analyze the variations in occurrence between different adult age groups. The study was done in 150 subjects in three age groups of 50 each. Individuals between 20 to 39 years were under group 1, 40 and 59 years under group 2 and 60 years and above were under group3. Sub-jects were selected from health camps and blood donation camps in and around Bangalore. Rheumatoid factor was tested by latex agglutination method, Anticardiolipin antibodies by ELISA and Antinuclear antibodies by indirect immunofluorescence method. Frequency of occurrence of all three autoantibodies especially that of ACLA was greater than ex-pected frequency in both group1 and 2. The frequency in elderly(group3) was increased as expected. Results also show that co-occurrence of more than one autoantibody in the same individual increases as age advances. Increase in RF, ACLA, ANA in apparently healthy individuals should be assessed carefully to prevent unnecessary treatment but at the same time they may need follow up to avoid missing early diagnosis of autoimmune disease.

Key words: Autoantibodies, Rhematoid Factor, Anticardiolipin antibody, antinuclear
Accepted February 23 2011

Introduction

In earlier decades of the twentieth century, the term “horror autotoxicus” by paul Erlich meaning autoanti-bodies were somehow prevented from destroying self antigens, found broad acceptance and it was believed that autoimmune diseases was an impossibility. This Percep-tion changed gradually when several studies demonstrated autoimmune diseases related to specific autoantibodies [1]. Since then many of these autoantibodies have been used in diagnosing autoimmune diseases.

Studies have also demonstrated that several specific sur-prisingly constant auto antibodies are present in all normal healthy individuals[2]. These are called as natural auto antibodies (na-Ab and have been shown to provide critical early protection against pathogens [3].

But recently autoantibodies like Rheumatoid factor(RF), Anticardiolipin antibody (ACLA) and Antinuclear anti-body (ANA), long acting thyroid stimulating antibody, anticytoplasmic antibody normally used in diagnosing autoimmune diseases have also been identified in healthy individuals [2]. The presence of such autoanti-bodies in healthy individuals could alter their diagnostic and predictive value.

Occurrence of these autoantibodies vary with age, geo-graphical location and other environmental factors [4].

Rheumatoid factor, Anticardiolipin antibody and Antinu-clear antibody are widely used in India to aid diagnosis of rheumatoid arthritis, thrombotic conditions and SLE respectively but its occurrence in healthy individuals is not much explored. This study was done as an attempt to find the occurrence of RF,ACLA and ANA in healthy adults in South Indian population. It was also done to analyze the variations in occurrence between different adult age groups.

Materials and Methods

The study was done in 150 subjects (68 males and 82 fe-males) in three age groups of 50 each. Individuals from 20 to 39 years were under group 1, those between 40 and 59 years were under group 2 and elderly subjects of 60 years and above were under group3. A comparable male : female ratio of 48 : 52 % was seen in younger age groups (group 1 and 2) but in the elderly group (group 3), females were higher by 20%. Health camps and blood donation camps were conducted in different semi urban areas in and around Bangalore to include a wider repre-sentative population. A proforma was used to collect their sociodemographic status and medical history of all the subjects attending the camps. Exclusion of predispos-ing risk factors ( autoimmune diseases, diabetes, chronic infection and malignancies ) was by history taking and general physical examination. Informed consent was ob-tained from all individuals. Blood samples were collected from all apparently healthy individuals and were investi-gated for the presence of autoantibodies. The blood sam-ples were stored at minus twenty degrees Celsius and tests were done for all samples at the same time in the immu-nology department of Ramaiah medical college Banga-lore. The study was approved by the Institutional review board.

Rheumatoid factor was tested by latex agglutination method(LAT) (using labkit code no 40121-100 test lot no 04). In routine practice, and particularly in developing countries such as India, LAT can still be the preferred method for RF determination when compared to nephelometry.[5] In this method polystyrene latex parti-cles were coated with IgG acts as the antigen and binds with the rheumatoid factor in the test sample which acts as the antibody. This binding results in an agglutination reaction which can be visualized through the naked eyes The latex reagent sensitivity was adjusted to detect a minimum of 8 IU/ml of rheumatoid factors according with the WHO international standard without previous sample dilution.

Anticardiolipin antibodies were tested by ELISA after house standardization [6,7]. Polystyrene microplate strips were coated with 50 μg/ml of lyophilized cardiolipin in ethanol which bind to the plate and used as the solid phase containing bound antigens. The unbound free anti-gens were washed away. 300μl of 10%FCS in PBS was added as blocking solution and this binds to any excess protein binding site in the microtitre plate after the bind-ing of the antigen. To this the diluted test sample was added and antibodies in the sample attach to the antigens coupled to the solid phase. The unbound proteins were washed off. In the next step, the attached antibodies were detected by binding with enzyme labeled Anti Human IgG peroxidase (diluted in FCS) antibodies. 50μl of TMB was added as substrate in each well and incubated at 37 °C for 15mts. 50μl of 0.1N H2SO4 was added to stop the reaction and the optical density(OD) reading was taken at 490 nm using an Elisa reader. Values above 20GPL for IgG and above 10GPL for IgM were taken as positive

Antinuclear antibodies were tested by indirect im-munofluorescence method[8] (using UI507 ANA HEP-2 BIODIAGNOSTICA LTD). Slides made from human epithelial cell line were used as the antigen substrate. Diluted human sera (test sample) was incubated with the substrate. Antibodies present in the sera bind to the anti-genic nuclei in the substrate forming antigen-antibody complexes. The unreacted antibodies were washed off. The substrate was then incubated with Human anti IgG rabbit globulins coupled with fluorescein isothiocyanate which binds with these complexes and the nuclear pattern appears apple green when viewed under a fluorescent mi-croscope. Slides showing patterns in greater than 40% with 1: 40 dilution were taken as positive.

Results

The total number of subjects positive for one or more autoantibodies in each age group (n=50) were 18(36%) in group 1, 18 (36%) in group 2 and 25 (50%) in group 3. The overall occurrence appeared to be the same (36%) in both Group1 and Group2. But when each autoantibody was considered separately the results were slightly higher in group 2 than that of group 1(table 1). This dif-ference was due to the co occurrence of any two autoanti-bodies in the same individual which was 8% in Group 2 where there was no co –occurrence in the 20-39 yrs Group(gp1). The co occurrence in the elderly group was 16% (gp3).

In group 1 and 2 (male : female ratio of 48 : 52 ) the frequency of RF, ACLA & ANA was 9, 22 and 9% in males and 7, 24 and 11% in females which shows that the increased occurrence in the younger age groups is not gender biased.

Among the autoantibodies studied IgG -ACLA was found to occur more frequently in all three groups with a total frequency of 28% (n=39/150) in comparison to 11% (n=17/150)of both RF and ANA. IgM ACLA was not much raised with an occurrence of only 5% (n=6/150)

Statistical Analysis was done to assess the variations in frequency between the three age groups. ANOVA and Chi square test were done using SPSS -ender 16 Pack-age. Significance was assessed at 5% level of signifi-cance. Table 2 shows the non significance between all three groups. Even though results showed a compara-tively higher frequency in the elderly group it was not statistically significant. This gives an important clinical implication as it can be attributed to the increased oc-currence in the younger Indian adults.

Table 1. Number of individuals positive for each autoantibody separately in each age group

  Group1
(20-39yrs)
(n=50)
Group2
(40-59yrs)
(n=50)
Group 3
(>/=60yrs)
(n=50)
Rheumatoid factor (RF) 3(6%) 5(10%) 9(18%)
Antinuclear antibody (ANA) 4(8%) 6(12%) 7(14%)
Anticardiolipin antibody (ACLA) 11(22%) 12(24%) 16(32%)
Total 18(36%) 18(36%) 25(50%)

Table 2. p values between all three groups showing statistical non significance(indicating clinical significance)

  Group 2 (40-59 yrs) Group 3 (60yrs and above)
  RF ACLA ANA RF ACLA ANA
Group1 20-39yrs 0.35 0.81 0.34 0.07 0.26 0.33
Group 2 -- -- -- 0.25 0.38 0.77

Table 3. Results of 3 other studies (12,13,14) on RF,ACLA and ANA done on younger and elderly age groups in compari-son with the results of this study

20 to 60 yrs vs ( 60yrs and above)
  Study no 1 Study no 2 Study no 3 present study
ACLA 2.3% (51%) 2% (12%) 1.2% (0%) 23% (32%)
ANA 0% (31% ) 1% (09%) 1.6% (08%) 10% (14%)
RF 1.6% (14%) 1.5% (12%) - (03%) 8% (18%)

Discussion

B lymphocytes which are responsible for humoral immu-nity have two opposite requirements. One is immune re-sponsiveness (ability to react against virtually any for-eign substance or antigen) and the other is immunological tolerance or self tolerance ( should not react against self antigens) which prevents autoimmune reaction. Some of the self tolerance mechanisms are central tolerance in bone marrow itself by apoptosis (clonal deletion) and peripheral tolerance mechanisms like clonal ignorance, effect of T suppressor cells on B cells and sequestration of antigens. Failure of these self tolerance mechanisms such as decrease in T cell suppression[9], defective apoptosis[10], release of sequestered antigens, molecular mimicry[11] result in the formation of autoantibodies.

These autoantibodies can be natural autoantibodies or can be pathogenic autoantibodies. A substantial proportion of circulating autoantibodies in healthy individuals exhibit polyreactivity and self-reactivity and these are referred to as natural autoantibodies (NAAs). NAAs play an impor-tant role in eliminating pathogens. These natural autoanti-bodies are subjected to regulatory mechanisms that prevent them from causing autoimmunity[3] The general network of na-Ab has been named Immunculus. Patho-logic changes at the molecular level, (Immunculus distor-tions) result in autoantibodies which precede or accom-pany different diseases and many of these autoantibodies like Rheumatoid factor(RF), Anticardiolipin antibody (ACLA) and Antinuclear antibody (ANA), long acting thyroid stimulating antibody, anticytoplasmic antibody have been used in diagnosing autoimmune diseases. Re-cent evidences show that some of the pathogenic autoan-tibodies used in diagnosing autoimmune diseases have also been identified in healthy individuals[2]. The pres-ence of such autoantibodies in healthy individuals could alter their diagnostic and predictive value.

A comparative analysis of the results of this study on the occurrence of RF,ACLA and ANA in healthy individuals with reports of other similar studies [12,13,14] show that the frequency of occurrence of autoantibodies in the elderly group > 60 years in other studies are almost the same as in this study. But, the frequency of occur-rence between 20 and 60 years is 8- 23% in this study whereas in other studies it is less than 3 %.

The reporting of increased autoantibodies with ageing has been consistent and one possible explanation for the in-crease is that naive T cell population decreases with ag-ing, and there is a shift from T helper 1 to T helper 2 cy-tokine profiles with stimulation, which could augment B cell-mediated autoimmune disorders. As the immune sys-tem shifts to a Th2 response, tolerance mechanisms fail and autoreactive antibodies increase [15]

The rationale for the increase in autoantobodies in the younger age groups is not well defined. One study suggests that exposure to infection in early life may produce distinct effects on different autoantibody syst-ems. In particular, diarrhoeal illness may have a particular role in the development of autoantibodies[16]. These could be considered as natural autoantibodies thereby enhancing host immune reaction to foreign agents [17] As diarrhea is commonly seen in India this could be a possible explanation for the increase in young adults. A review in Lancet states that autoantibodies associated with rheumatoid arthritis may predict disease in healthy individuals in whom hormonal changes might be a trigger for autoimmune disease. [18]

Two different retrospective studies on ANA [19] and RF [20] have shown that autoantibodies may be present many years before diagnosis of autoimmune disease, while patients are still asymptomatic. Another study re-ports that Populations such as doctors and relatives of patients with autoimmune disease tend to presents in-creased ANA titers. [21]

Thus the increased occurrence of RF,ACLA and ANA in Indian young adults could either be natural autoanti-bodies developing due to early exposure to environmental factors or it could be an indicator of preclinical stage of autoimmune disease.

Another study has shown that homosexuals may have higher levels of autoantibodies[22]but this has not been considered in the present study.

Conclusion

RF, ACLA & ANA are widely used as diagnostic pur-pose and an increase in apparently healthy individuals should be assessed carefully to prevent unnecessary treatment but at the same time they may need follow up to avoid missing early diagnosis of an autoimmune dis-ease. Autoantibodies may act as markers of future disease in presently healthy individuals.

Limitations

The trend in the occurrence of autoantibodies in Indian population can be seen by this study but the sample size is small and may not be sufficient to form a conclu-sive opinion. Long-term large studies of outcome are needed to assess the use of assaying autoantibodies.

Also the proportion of females in the elderly group is slightly higher but this does not affect the outcome of the study.

Acknowledgement

Immunology department of Ramaiah medical college and hospital, Bangalore.

References

  1. Noel R. Rose,Ian RM. The Autoimmune Diseases. 4th ed. London U.K: Elsevier Academic press, 2006: 4-5.
  2. Alexander Poletaev, Leeza Osipenko. General network of natural autoantibodies as immunological homuncu-lus (Immunculus). Autoimmunity Reviews 2003; 264-271.
  3. Agata Matejuk, Michael Beardall, Yang Xu, Qi Tian, Daniel Phillips, Boris Alabyev et al- Exclusion of Natural AutoantibodyProducing B Cells from IgG Memory B Cell Compartment during T Cell-Dependent Immune Responses. J Immunol 2009;182: 7634-7643.
  4. Ali A. Al-Jabri, Elizabeth R. Richens. Occurence of autoantibodies in healthy Omani individuals. SQU Journal For Scientific Research & Medical Sciences 2001; 1: 13-19.
  5. Venugopalan Anuradha, Arvind Chopra. In the era of nephelometry, latex agglutination is still good enough to detect rheumatoid factor. The Journal of Rheumatology December 1, 2005; vol. 32 ;no. 12: 2343-2344
  6. National Workshop on autoantibodies. Laboratory Manual; Sanjay Gandhi Institute Of Medical Sciences, Lucknow).
  7. Snowden N, Wilson PB, Longson M, Pumphrey RS. Antiphospholipid antibodies and Mycoplasma pneu-moniae infection. Postgrad Med J 1990; 66:356–62.
  8. I Peene, L Meheus, E M Veys, F De Keyser. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing. Ann Rheum Dis 2001;60:1131–1136
  9. Gibson T, Basten A, Walker K.Z, LoblayR.H – A role for suppressor T cells ininduction of self tolerance. Proc. Nat l. Acad. Sci. Usa August 1985; 82: 5150-5154.
  10. M.Salmon, C.Gordon – Role of apoptosis in systemic lupus erythemetosis. Rheumatology 1999; 38 (12): 1177-1183
  11. Ruth Hannon, Charlotte Pooler, Carol Mattson Porth – Porth Pathophysiology: Concepts of Altered Health States.1st ed. Lippincott Williams & Wilkins, 2010: 407-408
  12. Manoussakis MN, Tzioufas AG, Silis MP, Pange PJ, Goudevenos J, Moutsopoulos HM. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin. Exp. Immunol 1987; 69: 557-565.
  13. Fields RA, Toubbeh H, Searles RP, Bankhurst AD. The prevalence of anticardiolipin antibodies in a healthy elderly population and its association with antinuclear antibodies. J Rheumatol. 1989;16:623-625.
  14. Angela. G, Juby MD, Paul Davis. MD – Prevalence and disease associatons of certain autoantibodies in elderly patients. Clin Invest Med 1998; 21 (1): 4-11
  15. Kimberly P. Liang, Sherine E. Gabriel- Autoantibodies: innocent bystander or key player in immunosenescence and atherosclerosis? J Rheumatol. 2007 Jun; 34(6): 1203-1207.
  16. C.J Edwards,H. K. Jameson, Goswami P, E.L. Williams, R. Polosa R. Goswami, et al and the Hertfordshire Cohort Study Group. The presence of anticardiolipin antibodies in adults may be influenced by infections in infancy. QJM. An international journal of medicine 2008; 101 (1): 41-47.
  17. Yaron Tomer, Yehuda Shoenfeld. The Significance of Natural autoantibodies. Immunological Investigations 5 July 1988; 17: 389-424.
  18. R Hal Scofield. Autoantibodies as predictors of disease Lancet May 8 2004; vol 363: 1544–1546.
  19. Melissa R. Arbuckle, Micah T. McClain, Mark V. Ru-bertone, R. Hal Scofield, Gregory J. Dennis, Judith A. James et al – Development of Autoantibodies before the Clinical Onset of Systemic Lupus Erythematosus. N Engl J Med 2003; 349:1526-1533.
  20. Markus M. J. Nielen, Dirkjan van Schaardenburg, Henk W. Reesink, Rob J. van de Stadt, Irene E. van der Horst, Bruinsma,Margret H. M. T. de Koning et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: A study of serial measurements in blood donors. Arthritis & Rheumatism February 2004; Volume 50, Issue 2: 380–386.
  21. Marin GG, Cardiel MH, Cornejo H, Viveros ME. Prevalence of antinuclear antibodies in 3 groups of healthy individuals: blood donors, hospital personnel, and relatives of patients with autoimmune diseases. J Clin Rheumatol. 2009; 15 (7): 325-329.
  22. Mulhall BP, Naselli G, Whittingham S. Anticardiolipin antibodies in homosexual men: prevalence and lack of association with human immunodeficiency virus (HIV) infection. J Clin Immunol. 1989 May; 9 (3): 208-213.

Correspondence to:
Lingaraj Jayalakshmi

Department of Physiology
Vydehi Institute of Medical Sciences and Research Center
Bangalore, India

Biomedical Research 2011 Volume 22 Issue 3 345

Access free medical resources from Wiley-Blackwell now!

About Indmedica - Conditions of Usage - Advertise On Indmedica - Contact Us

Copyright © 2005 Indmedica